Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds

Basit Öğe Kaydı
dc.authorid0000-0003-0230-6575
dc.authorid0000-0003-2714-4584
dc.authorid0000-0002-4951-6716
dc.contributor.authorÇakal, Beytullah
dc.contributor.authorÇakal, Sinem
dc.contributor.authorBoztosun, Bilal
dc.date.accessioned2020-12-25T10:29:16Z
dc.date.available2020-12-25T10:29:16Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.description.abstractBACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results would be true when a different type of BVS isused. This study sought to evaluate the long-term performance ofnovolimus-eluting bioresorbable vascular scaffolds (nBVSs) comparedwith everolimus-eluting bioresorbable vascular scaffolds (eBVS).METHODS A total of 140 patients with nBVS (n ¼ 202 before exclusion) and 98 patients with eBVS (n ¼ 135 before exclusion) wereincluded in current study. After propensity-score matching, 98 patients treated with 135 eBVSs were compared with 98 patients treatedwith 136 nBVSs. The primary outcome was the 3-year rate of majoradverse cardiovascular events, defined as the composite of cardiacdeath, target vessel myocardial infarction, and target lesionrevascularization.
dc.identifier.citationÇakal, B., Çakal, S. ve Boztosun, B. (2020). Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds. 32nd Annual Transcatheter Cardiovascular Therapeutics Symposium (TCT CONNECT) içinde (B118-B119. ss.). Electr Network, October 14-18, 2020.
dc.identifier.endpageB119
dc.identifier.issn0735-1097
dc.identifier.issn1558-3597
dc.identifier.issue17
dc.identifier.startpageB118
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6146
dc.identifier.volume76
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartof32nd Annual Transcatheter Cardiovascular Therapeutics Symposium (TCT CONNECT)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectBioresorbable Vascular Scaffolds
dc.subjectEverolimus
dc.subjectNovolimus
dc.titleLong-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Cakal-Beytullah-2020.pdf
Boyut:
231.78 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu